↓ Skip to main content

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience

Overview of attention for article published in Frontiers in oncology, October 2022
Altmetric Badge
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
Published in
Frontiers in oncology, October 2022
DOI 10.3389/fonc.2022.1028118
Pubmed ID
Authors

Li-Ching Lin, Wen-Kuan Huang, Chueh-Chuan Yen, Ching-Yao Yang, Meng-Ta Sung, Natalie S.M. Wong, Daniel T. T. Chua, Sarah W. M. Lee, Jen-Shi Chen, Chun-Nan Yeh

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer